Development of clinical models for predicting erectile function after localized prostate cancer treatment.

Autor: Haskins AE; Center for Outcomes Research and Evaluation, Maine Medical Center, Portland, Maine, USA., Han PK, Lucas FL, Bristol I, Hansen M
Jazyk: angličtina
Zdroj: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2014 Dec; Vol. 21 (12), pp. 1227-33. Date of Electronic Publication: 2014 Jul 23.
DOI: 10.1111/iju.12566
Abstrakt: Objectives: To develop clinical prediction models estimating the probability of maintaining erections adequate for intercourse 2 years after prostate cancer treatment, based on pretreatment characteristics.
Methods: Study participants consisted of prostate cancer patients with localized disease and functional erections before undergoing surgery (n = 536) or radiation therapy (n = 240) at a single USA institution. Baseline patient- and treatment-related data were collected from a clinical database and through chart review. Erectile function at 2 years post-treatment was prospectively assessed through a self-administered single-item measure. Multivariate logistic regression using backward selection was used to derive clinical prediction models to predict erectile function at 2 years for surgery and radiation therapy patients; the models were internally validated using bootstrapping methods.
Results: The final prediction model for surgery patients included the predictor variables of age, body mass index, smoking, diabetes, hypertension and nerve-sparing procedures, whereas the model for radiation therapy patients included hypertension, risk category and radiation technique. The new models showed acceptable calibration and discrimination: c-statistic = 0.71 (95% confidence interval 0.68-0.76) for surgery and 0.66 (95% confidence interval 0.61-0.74) for radiation therapy models.
Conclusions: New clinical prediction models based on patient and treatment characteristics show promising accuracy in predicting erectile function at 2 years in patients treated with surgery and radiation for localized prostate cancer. More work is required to confirm and validate these models in different patient populations.
(© 2014 The Japanese Urological Association.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje